Fake data from trial sites ruin studies, drug firms say

Science 2026

View at publisher
Authors: Charles Piller
DOI: 10.1126/science.aef2599
Cited by: 0

Abstract

Alzheimer's drug developer accuses companies it hired of providing "medically impossible" results.

Fields of Study & Subjects

Science Research and Medicine Global Public Health Policies and Epidemiology Pharmaceutical industry and healthcare

Publication details

Journal / source
Science
Volume
391
Issue
6781
Pages
112–114
Publication date
8 January 2026
Language
EN